Statin Medications & Heart Disease

Statins or HMG-CoA reductase inhibitors, are used clinically to lower cholesterol levels and have been associated with decreased risk of heart disease. Discover the latest research on Statin Medications & Heart Disease here.

September 15, 2020

Stain Associated Autoimmune Myopathy: Case Report With Delayed Onset and Treatment Challenges

Journal of Pharmacy Practice
Robert BarronsRyan Humphries
August 28, 2020
Open Access

Low-Density Lipoprotein Cholesterol Targets in Patients With Coronary Heart Disease in Extremadura (Spain): LYNX Registry

Cardiology Research
Jose Javier Gomez-BarradoYolanda Porras Ramos
August 26, 2020

Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD

Cardiovascular Drugs and Therapy
Dhruv MahttaSalim S Virani
September 22, 2020

Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis

Lipids in Health and Disease
Agata Bielecka-DabrowaMaciej Banach
August 22, 2020

Updates in Anti-anginal and Anti-ischemic Therapies for Acute Coronary Syndromes

Current Cardiology Reports
Abhizith DeokerDebabrata Mukherjee
August 22, 2020

Prevalence Of familial hypercholeSTerolaemia (FH) in Italian Patients with coronary artERy disease: The POSTER study

Michele Massimo GuliziaPOSTER Investigators
September 6, 2020

Successful Implementation of the Exercise First Approach for Intermittent Claudication in the Netherlands is Associated with Few Lower Limb Revascularisations

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
Sandra C P JansenAnco C Vahl
September 14, 2020
Open Access

Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes

Cardiovascular Diabetology
Pham Viet ThaiPaul Valensi
September 18, 2020

Nephrologist Follow-Up Care of Patients With Acute Kidney Disease Improves Outcomes: Taiwan Experience

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Vin-Cent WuLakhmir S Chawla
August 25, 2020
Open Access

Long Term Clinical Outcomes of Patients with Ischemic Stroke in Primary care – A 9-year Retrospective Study

Jinghao HanMaria Kwan Wa Leung
September 1, 2020

Hepatocellular Carcinoma and Statins

Ghazal Alipour TaleshAksam Merched
September 18, 2020
Open Access

LDL/Apo B ratio and Lp (a) Each Predict Coronary Artery Disease in Type2 Diabetes Independent of ASCVD Risk Score: A Case-Cohort Study

MedRxiv : the Preprint Server for Health Sciences
S. RabizadehAlireza Esteghamati
September 22, 2020

Determinants of ST-segment elevation myocardial infarction as clinical presentation of acute coronary syndrome

Journal of Thrombosis and Thrombolysis
Osamu KuriharaIk -Kyung Jang
August 22, 2020
Open Access

Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol

Journal of Lipid and Atherosclerosis
Doo Sun SimKorea Acute Myocardial Infarction Registry-National Institutes of Health (KAMIR-NIH) registry investigators

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

© 2020 Meta ULC. All rights reserved